These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9009249

  • 1. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside.
    Viallard JF, Grosset C, Lacombe F, David S, Mahon FX, Barbot C, Vianes I, Dupouy M, Reiffers J.
    Leuk Res; 1996; 20(11-12):915-23. PubMed ID: 9009249
    [Abstract] [Full Text] [Related]

  • 2. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia.
    Inatomi Y, Toyama K, Clark SC, Shimizu K, Miyauchi J.
    Cancer Res; 1994 Jan 15; 54(2):455-62. PubMed ID: 7506123
    [Abstract] [Full Text] [Related]

  • 3. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.
    Andreeff M, Tafuri A, Hegewisch-Becker S.
    Haematol Blood Transfus; 1990 Jan 15; 33():747-62. PubMed ID: 2323674
    [Abstract] [Full Text] [Related]

  • 4. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 5. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug 15; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 6. Influence of rhGM-CSF on Ara-C sensitivity of patients with acute myeloid leukemia in relapse: a flow cytometry study.
    Lacombe F, Puntous M, Dumain P, Cony-Makhoul P, Belloc F, Bernard P, Boisseau M, Reiffers J.
    Leuk Res; 1996 Jun 15; 20(6):481-9. PubMed ID: 8709620
    [Abstract] [Full Text] [Related]

  • 7. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
    Gotoh A, Kawanishi Y, Kurosawa K, Miyazawa K, Ohtaka M, Aizawa S, Kimura Y, Yoshikawa O, Toyama K.
    Rinsho Ketsueki; 1993 Jul 15; 34(7):821-8. PubMed ID: 7689660
    [Abstract] [Full Text] [Related]

  • 8. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH, Talpaz M, Deisseroth AB, Estrov Z.
    Leukemia; 1996 May 15; 10(5):757-65. PubMed ID: 8656668
    [Abstract] [Full Text] [Related]

  • 9. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA, Löwenberg B, Sonneveld P.
    Leukemia; 1994 Sep 15; 8(9):1480-6. PubMed ID: 7522289
    [Abstract] [Full Text] [Related]

  • 10. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
    Nara N, Tanikawa S, Nagata K, Hamaguchi H, Tomiyama J.
    Int J Hematol; 1993 Aug 15; 58(1-2):27-35. PubMed ID: 7693028
    [Abstract] [Full Text] [Related]

  • 11. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors.
    Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo K, Welte K.
    Blood; 1992 Sep 01; 80(5):1199-206. PubMed ID: 1381238
    [Abstract] [Full Text] [Related]

  • 12. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT, Zander A.
    Acta Haematol; 1996 Sep 01; 95(3-4):257-62. PubMed ID: 8677752
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the cytotoxicity of cytosine arabinoside by interleukin-3.
    Tanaka M.
    Jpn J Cancer Res; 1992 Feb 01; 83(2):194-9. PubMed ID: 1556000
    [Abstract] [Full Text] [Related]

  • 14. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M.
    Leukemia; 1994 May 01; 8(5):749-57. PubMed ID: 7514244
    [Abstract] [Full Text] [Related]

  • 15. Haemopoietic growth factors, the cell cycle of acute myeloblastic leukaemia progenitors and sensitivity to cytosine arabinoside.
    Smith MA, Smith JG, Pallister CJ, Singer CR.
    Leuk Lymphoma; 1996 Nov 01; 23(5-6):467-72. PubMed ID: 9031077
    [Abstract] [Full Text] [Related]

  • 16. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C.
    Exp Hematol; 1991 May 01; 19(4):267-72. PubMed ID: 2055291
    [Abstract] [Full Text] [Related]

  • 17. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool.
    Carlesso N, Pregno P, Bresso P, Gallo E, Pileri A, Zsebo KM, Ferrero D.
    Leukemia; 1992 Jul 01; 6(7):642-8. PubMed ID: 1378162
    [Abstract] [Full Text] [Related]

  • 18. Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blasts.
    Wetzler M, Bernstein SH, Baumann H, Fries KM, Stewart C, Blumenson L, Baer MR, Herzig GP, Bloomfield CD, Slack JL.
    Leuk Lymphoma; 1998 Aug 01; 30(5-6):415-31. PubMed ID: 9711904
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr 01; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 20. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
    Hedley DW, McCulloch EA.
    Leukemia; 1996 Jul 01; 10(7):1143-9. PubMed ID: 8683994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.